Microchannel Mesotherapy Trademark Application Published for Opposition
The USPTO has published a trademark application for "Microchannel Mesotherapy" for opposition. The application covers a range of medical and aesthetic services, including consultations, skin treatments, and drug delivery systems. The publication date is March 22, 2026.
USPTO Trademark Application Filed for Medical Imaging Apparatus
The USPTO has received an intent-to-use trademark application for the mark "INFANT IMAGING WITH EASE" for medical imaging apparatus. The application was filed on December 23, 2024, and is designated for Class 010.
MICROTOUCH Trademark Application for Medical Apparatus
The USPTO has received an intent-to-use trademark application for the mark MICROTOUCH. The application covers a wide range of medical diagnostic and radiological apparatus, as well as related business and retail services. The filing date indicates a future intent to use the mark.
USPTO Trademark Application for Surgical and Medical Apparatus
The USPTO has received an intent-to-use trademark application for 'SURGISTAMP' for surgical and medical apparatus. The application was filed on November 12, 2025, with an intended use date of March 22, 2026. This filing pertains to Class 010 trademarks.
USPTO Trademark Application for CLAIR AI Healthcare Insights
The USPTO has received an intent-to-use trademark application for the mark 'CLAIR' for AI-driven healthcare insights, wearables, and biometric data services. The application covers a wide range of services related to women's health, hormone tracking, and personalized health recommendations.
USPTO Trademark Application for Wearable Hormone Trackers
The USPTO has received an intent-to-use trademark application for wearable hormone trackers and health monitoring software. The application covers a range of electronic devices, sensors, and AI-powered software for tracking women's health data, including hormone levels, fertility, and providing personalized health insights.
CELLSCOUT Medical Device Trademark Application
The USPTO has received an intent-to-use trademark application for the mark CELLSCOUT. The application covers medical devices for diagnosing diseases, including those involving the esophagus, and diagnostic apparatus for detecting biomarkers associated with esophageal diseases.
USPTO Trademark Application - PYLON EXPANDABLE CERVICAL CORPECTOMY
The USPTO has received an intent-to-use trademark application for 'PYLON EXPANDABLE CERVICAL CORPECTOMY' filed on March 20, 2026. The application covers medical devices, specifically spinal and vertebral implants made from artificial materials.
USPTO Trademark Filing for MITUS Surgical Instruments
The USPTO has received an intent-to-use trademark application (TM99714481) for the mark MITUS, intended for use with surgical instruments and apparatus. The filing date was March 20, 2026.
USPTO Trademark Application for MITUS Surgical Instruments
The USPTO has received an intent-to-use trademark application for the mark "MITUS" filed on March 21, 2026. The application covers surgical instruments and apparatus. This is a routine filing for a new trademark.
DOVE CLEAR Dental Valve Evacuation Device Trademark Application
The USPTO has received an intent-to-use trademark application for 'DOVE CLEAR', a dental valve evacuation device. The application was filed on March 20, 2026, with an intended use date of March 21, 2026. This filing pertains to Class 010 for medical devices.
USPTO Trademark Application for Sleep Disorder Medical Devices
The USPTO has received an intent-to-use trademark application (TM99716311) for medical devices intended for treating sleep disorders. The application was filed on March 21, 2026, with an intended use date of March 22, 2026.
USPTO Trademark Application for UTER-ICE
The USPTO has received an intent-to-use trademark application for the mark UTER-ICE, intended for use with therapeutic hot and cold therapy packs. The application was filed on November 19, 2025, with an expected use date of March 22, 2026.
USPTO Trademark Application: CHOMP-CHAMP
The USPTO has received an intent-to-use trademark application (TM99492824) for 'CHOMP-CHAMP', described as therapeutic chewing devices for oral sensory stimulation. The application was filed on November 12, 2025, with an intent-to-use date of March 22, 2026.
KSAHUHU Trademark Application - Medical Instruments and Devices
The USPTO has received an intent-to-use trademark application for the mark KSAHUHU. The application covers a range of medical instruments and devices, including abdominal belts, electric blankets for medical purposes, massage apparatus, and orthopedic braces. The filing date for this application was November 12, 2025.
HYDROSLIX Trademark Application for Medical/Therapeutic Hydrogel Products
The USPTO has received an intent-to-use trademark application for the mark HYDROSLIX, filed on November 12, 2025. The application covers a range of products including personal lubricants, hydrogels for medical and therapeutic purposes, and various hydrogel-based personal care and sex toy items.
USPTO Trademark Application for IKANG - Medical Devices
The USPTO has received an intent-to-use trademark application (TM99492477) from IKANG for various medical devices, instruments, and related services. The application was filed on November 12, 2025, with an intended use date of March 22, 2026.
Novosorb BTM Burn Trademark Application
The USPTO has received an intent-to-use trademark application for "NOVOSORB BTM BURN" filed by an unnamed applicant. The application covers a range of surgical grafts, artificial skin, and wound care products made from artificial and biological materials.
USPTO Trademark Application for Spinal Implants
The USPTO has received an intent-to-use trademark application for medical devices, specifically spinal implants composed of artificial materials. The application was filed on November 7, 2025, with an effective date of March 22, 2026.
KNEFY Trademark Application for Sit-to-Stand Device
The USPTO has received an intent-to-use trademark application for the mark KNEFY, associated with an adjustable sit-to-stand assistive device. The application, filed on October 20, 2025, also covers related mobility aids and medical equipment.
Kinetura therapeutic body-care applicator trademark application
Kinetura therapeutic body-care applicator trademark application
USPTO Trademark Application for Diagnostic and Scientific Instruments
The USPTO has received an intent-to-use trademark application (TM99497564) for various chemical preparations, reagents, and diagnostic instruments. The application covers goods intended for industrial, research, scientific, and diagnostic purposes, excluding direct medical use.
USPTO Trademark Application for Diagnostic Apparatus and Reagents
The USPTO has received an intent-to-use trademark application (TM99497177) for diagnostic apparatus, instruments, and reagents. The application covers a broad range of products for detecting microorganisms and biological threats for medical, veterinary, industrial, and research purposes.
TEDSKIN Trademark Application - Medical Instruments
The USPTO has received an intent-to-use trademark application for the mark TEDSKIN, filed on November 12, 2025. The application covers a range of medical instruments and devices, including those for cardiac and brain condition checking, monitoring, and diagnostics, as well as related software.
SEKUREON Trademark Application for Medical Devices and Exercise Equipment
The USPTO has received an intent-to-use trademark application for the mark SEKUREON. The application covers a range of medical and therapeutic devices, including exercise equipment for rehabilitation, as well as various cell phone accessories and related electronic device components.
BREASTOX Trademark Application - Medical Diagnostic Apparatus
The USPTO has received an intent-to-use trademark application for 'BREASTOX' for medical diagnostic apparatus and DNA screening kits. The application covers a range of products and services related to medical specimen collection, DNA testing, and related medical consultancy.
BEST TAPE Trademark Application - Medical Adhesive Tapes
The USPTO has received an intent-to-use trademark application for "BEST TAPE" for medical and veterinary adhesive tapes, bandages, and elastic therapeutic tape. The application was filed on March 20, 2026, with an intended use date of March 21, 2026.
USPTO Trademark Application for RENASENSE
The USPTO has received an intent-to-use trademark application for the mark RENASENSE. The application covers medical instruments including glucose meters, blood glucose meters, and electrochemical sensors for medical purposes. The filing date for this application was March 20, 2026.
VITARA EXTEND Trademark Application - Neonatal Care Device
The USPTO has received an intent-to-use trademark application for the mark 'VITARA EXTEND' for a medical device intended for neonatal care. The device is described as a fluid-filled therapeutic system designed to simulate a womb-like environment for premature babies.
ONEPULSE Trademark for Medical Devices
The USPTO has received an intent-to-use trademark application for the mark "ONEPULSE" for a range of medical devices and instruments. The application covers devices for skin treatment, body shaping, pain management, and other therapeutic uses, with a filing date of March 20, 2026.
USPTO Trademark Application for Medical Instrument Organizer
The USPTO has received an intent-to-use trademark application for "STEADY HANDS NURSING SUPPORTING THE HANDS THAT CARE" for retail store services featuring medical supplies and nursing equipment. The application also covers printed training materials and a medical supply organizer for pediatric resuscitation.
NEUROAXISS Trademark Filing for Massage Apparatus
The USPTO has received an intent-to-use trademark application for the mark NEUROAXISS. The application covers massage apparatus and related personal use massaging devices. The filing date was March 20, 2026.
USPTO Trademark Application for OSSEOPRESS Dental Surgical Instruments
The USPTO has published an intent-to-use trademark application for the mark OSSEOPRESS, intended for use with surgical apparatus and instruments for dental use. The application was filed on March 20, 2026.
Phillips Medisize Trademark Filing for Medical Instruments
Phillips Medisize has filed an intent-to-use trademark application (TM99714483) with the USPTO for medical instruments. The filing covers drug delivery devices, nebulizers, and inhalers, with an intended use date of March 21, 2026.
USPTO Trademark Application for RESPIRE Medical Device Stent
The USPTO has received an intent-to-use trademark application for the mark 'RESPIRE' for use with medical devices, specifically stents. The application was filed on March 20, 2026.
USPTO Trademark Application for LSC AQUAMEDIX
The USPTO has received an intent-to-use trademark application for the mark LSC AQUAMEDIX. The application covers medical transport bags for carrying medical supplies and specimens. The filing date was March 20, 2026, with an intended use date of March 21, 2026.
USPTO Trademark Application for Medical Imaging Apparatus
The USPTO has received an intent-to-use trademark application for "THE REAL THING" related to various medical imaging apparatus. The application covers items such as electromagnetic and ultrasonic imaging apparatus, magnetic resonance imaging apparatus, and embedded software for medical devices.
USPTO Trademark Application: PEPTAPE for Scar Treatment
The USPTO has received an intent-to-use trademark application for the mark PEPTAPE, intended for use with hydrogel sheeting for scar treatment. The application was filed on March 20, 2026, with an expected effective date of March 21, 2026.
USPTO Trademark Application for CPAP Tubing
The USPTO has received an intent-to-use trademark application for "CPAP tubing" filed on March 20, 2026. This application pertains to tubing intended for use with continuous positive airway pressure devices.
USPTO Trademark Application: ERYTHROS LASER PRO
The USPTO has received an intent-to-use trademark application for 'ERYTHROS LASER PRO' for therapeutic LED masks and related medical apparatus. The application was filed on March 21, 2026, with an intended use date of March 22, 2026.
World TB Day 2026: End TB in Alabama
The Alabama Department of Public Health (ADPH) issued a notice for World Tuberculosis Day 2026, highlighting efforts to end TB in Alabama. The notice provides statistics on TB incidence and emphasizes the importance of community engagement, early diagnosis, and treatment to eliminate TB as a public health threat.
HSA Singapore New Drug Approvals - January 2026
HSA Singapore announced new drug approvals for January 2026. This notice serves to inform stakeholders of the latest additions to the approved drug list.
Keynote on Longevity Innovation, Regulation, and Collaboration
The Health Sciences Authority (HSA) of Singapore has published the text of a keynote address discussing innovation in longevity, the regulatory landscape, and the importance of collaboration. The speech highlights the evolving field of longevity and the need for regulatory frameworks to keep pace with scientific advancements.
NARSskin Night Treatment Recalled Due to Sudan IV Detection
The Health Sciences Authority (HSA) of Singapore has initiated a retail-level recall for all batches of NARSskin light reflecting restorative night treatment. The product was found to contain Sudan IV, a substance not permitted in cosmetic products, during a quality surveillance program. Local company Shiseido Singapore Co. (Pte) Limited is instructed to stop supplying the product and return existing stocks.
HSA Singapore SG-eCTD Version 1.1 Package Update
The Health Sciences Authority (HSA) of Singapore has released an updated package for SG-eCTD version 1.1. This update pertains to the electronic Common Technical Document submission format used for regulatory filings.
HSA Singapore: Adverse Effects from Banned Medicinal Products
HSA Singapore has issued a notice regarding adverse effects reported after consumers took banned medicinal products. The agency is highlighting the risks associated with using unapproved health products and urges consumers to exercise caution.
MHRA Class 2 Medicines Recall: Hibiwash 500ml due to Microbial Contamination
The MHRA has issued a Class 2 Medicines Recall for Hibiwash 500ml manufactured by Regent Medical Limited / Mölnlycke Health Care due to microbial contamination. Specific batches are affected, and the recall is being conducted to protect public health.
WHO and Partners Launch Digital Health Wallets for ASEAN
The WHO, in partnership with the Temasek Foundation, has launched a three-year initiative to help ASEAN Member States transition from paper-based health records to digital health wallets. This program aims to strengthen national health systems and improve continuity of care by providing trusted, portable access to essential health information.
ANSM Surveillance of Ixchiq Vaccine Adverse Effects
The French National Agency for the Safety of Medicines and Health Products (ANSM) is continuing its surveillance of adverse effects associated with the Ixchiq vaccine, used for chikungunya prevention. This notice serves to inform the public and healthcare professionals about ongoing monitoring activities.
EMA CHMP Meeting Agenda March 2026
The European Medicines Agency (EMA) has published the agenda for the Committee for Medicinal Products for Human Use (CHMP) meeting scheduled for March 23-26, 2026. The agenda outlines discussions on various medicinal products, including initial applications, oral explanations for pre-authorisation, re-examination, and post-authorisation procedures.
CHMP Meeting Agenda Annex Lists 22 Products Under Review
EMA published the annex to the CHMP meeting agenda for 23-26 March 2026 (EMA/CHMP/49808/2026), covering 22 pharmaceutical products across annual reassessments, PSUR procedures, renewals, and variation type IB updates. Products under review include Lojuxta, Raxone, Defitelio, CARVYKTI, Fycompa, Tecvayli, Qdenga, RINVOQ, Kapruvia, Voxzogo, ALTUVOCT, Ezmekly, Lytgobi, Rozlytrek, Duvyzat, Aucatzyl, Fingolimod Mylan, Cometriq, Bylvay KAYFANDA, Imatinib Teva, Ranivisio Epruvy, Xarelto, Forxiga/Xigduo/Qtern/Edistride/Ebymect. This is a procedural working document; it does not create compliance obligations.
Ohio Department of Health Podcast Discusses Heart Disease Prevention
The Ohio Department of Health has released a new podcast episode discussing heart disease prevention strategies. The episode features Dr. Bruce Vanderhoff and Dr. Joshua Joseph, covering lifestyle changes such as diet, exercise, stress reduction, and sleep quality to improve heart health.
ANSM Safety Information: Vitros MicroSlide Mg Reagent
The French ANSM has issued a safety alert regarding the Vitros MicroSlide Mg reagent from QuidelOrtho. Affected users have been notified directly by the company, and the action is registered under ANSM number R2607971. This notice provides information and a link to the company's safety communication.
ANSM Safety Information: Thoraflex Hybrid Thoracic Aorta Prosthesis
The French National Agency for Medicines and Health Products Safety (ANSM) has issued a safety alert regarding the Thoraflex Hybrid thoracic aorta prosthesis manufactured by Vascutek Ltd. Healthcare providers have been notified of a safety action implemented by the manufacturer.
ANSM Safety Recall: Quadripod Cane 548 bis HMS-Vilgo
The French National Agency for Medicines and Health Products Safety (ANSM) has announced a safety recall (R2608257) for the Quadripod cane model 548 bis HMS-Vilgo, initiated by the manufacturer HMS-Vilgo. The recall is directed at pharmacies, healthcare facilities, and home health providers.
ANSM Safety Alert: Space Plus Perfusor Syringe Pump by B Braun
The French National Agency for the Safety of Medicines and Health Products (ANSM) has issued a safety alert regarding the Space Plus Perfusor syringe pump manufactured by B Braun Melsungen AG. This alert informs healthcare facilities and pharmacies about a safety action implemented by the manufacturer.
DEA Seizes 215lbs Meth, Sentences Drug Trafficking Leader
The DEA announced the seizure of over 215 pounds of methamphetamine and the sentencing of Cesar Delfin-Cervantes to nearly 16 years in prison. Delfin-Cervantes was identified as a leader in a multi-state and international drug trafficking organization.
FDA Advisory Letters Notify Firms of Federal Law Violations
The FDA's Center for Veterinary Medicine is posting Untitled Letters on its website to inform the public about firms violating federal law. These letters notify firms of violations that do not meet the threshold for a Warning Letter but still require correction.
FDA CBER Issues Untitled Letters for Violations
The FDA's Center for Biologics Evaluation and Research (CBER) issues untitled letters to regulated industries for violations that do not meet the threshold for a Warning Letter. These letters address issues found in advertising and promotional labeling, bioresearch monitoring, and internet surveillance.
FDA Untitled Letters Issued 2011-2018
The FDA has posted a collection of 83 untitled letters issued between 2011 and 2018 by its Center for Food Safety and Applied Nutrition (CFSAN). These letters address violations related to manufacturing controls or labeling that did not meet the threshold for a Warning Letter.
FDA Untitled Letters to Pharmaceutical Companies
The FDA's CDER Freedom of Information Office has published a list of 34 untitled letters issued to pharmaceutical companies between February 2026 and September 2025. These letters address promotional communications for various prescription drugs, indicating potential violations of FDA regulations regarding drug advertising and promotion.
FDA SKOUT system K253664 Medical Device Notification
The FDA has published a 510(k) premarket notification for the SKOUT system (K253664). This notification indicates a new medical device has been cleared for market. Further details on the device's specific function and intended use are available through the provided FDA database link.
FDA K253532: TruSPECT Processing Station Submission
The FDA has published a 510(k) premarket notification submission for the TruSPECT Processing Station, identified by K253532. This notification indicates a new device is being reviewed or has been cleared by the FDA.
FDA 510(k) Premarket Notification - AIR Recon DL
The FDA has published a 510(k) premarket notification for the AIR Recon DL, a device from GE Medical Systems. This notification indicates the device has undergone a review process to demonstrate substantial equivalence to legally marketed predicate devices.
FDA ART-Plan+ Medical Device Premarket Notification
The FDA has published a premarket notification (510(k)) for the ART-Plan+ medical device. This notification details the device's compliance with regulatory requirements for market entry. The document is part of the FDA's public database for medical device approvals.
FDA PeekMed Radiology Software 510(k) Notification
The FDA has published a 510(k) premarket notification for PeekMed web radiology software. This notification indicates that the software has met the requirements for market entry, allowing it to be used by healthcare providers.
SHOMOOL Trademark Renewal - Medical Diagnosis Services
The USPTO has renewed the trademark 'SHOMOOL' (TM97385700) for medical diagnosis and testing services. The renewal is effective until March 22, 2026, covering services such as genetic testing and disease diagnosis.
NATURASOPHIA Trademark Renewal
The USPTO has renewed the NATURASOPHIA trademark (TM97362675) for medical and cosmetic services and products. The renewal is effective March 22, 2026, and was filed on April 14, 2022.
Muntons Traditional Plant Supports Trademark Renewal
The USPTO has renewed the trademark 'Muntons Traditional Plant Supports' (TM97540588), originally filed on August 9, 2022. The renewal is effective until March 22, 2026, covering services related to gardening, horticulture, and landscape design, as well as metal garden products.
Shomool Trademark Renewal - Prenatal Diagnosis Services
The USPTO has renewed the trademark 'Shomool' for services including medical diagnosis and genetic testing for autosomal recessive disorders. The renewal is effective March 22, 2026, and covers services such as healthcare, medical diagnosis, and performing disease diagnosis.
DEEPPSY Trademark Renewal for Medical Services
The United States Patent and Trademark Office (USPTO) has renewed the trademark 'DEEPPSY' (TM97551722) for medical services, including electronic apparatus for cell testing, medical software for brain disorders, and medical research. The renewal is effective March 22, 2026.
USPTO Trademark Renewal: NU NU SENSUELLE for Massage Devices
The United States Patent and Trademark Office (USPTO) has renewed the trademark 'NU NU SENSUELLE' (TM90562744) for massage devices. The renewal is effective March 22, 2026, and covers apparatuses for vibrating or stimulating the body.
USPTO Trademark Renewal for NU Massage Devices
The USPTO has renewed the trademark registration for NU, which covers massage devices. The renewal was effective on March 22, 2026, and the original filing date for the trademark was March 5, 2021.
LOKSNAP Trademark Renewal - Medical Instruments
The USPTO has renewed the LOKSNAP trademark (TM97404687) for a list of medical instruments, including syringes, needles, and injection devices. The renewal was effective March 22, 2026, following a filing date of May 11, 2022.
USPTO Trademark Renewal for Medical Instruments
The USPTO has renewed trademark application TM97409428 for a variety of medical instruments, including syringes, needles, and injection devices. The renewal is effective March 22, 2026.
USPTO Trademark Renewal for OLDRIV - Medical Instruments
The USPTO has renewed the trademark application TM88926287 for the mark OLDRIV, which covers a range of medical instruments and devices. The renewal was processed on March 22, 2026, with an original filing date of May 20, 2020.
VETONE PROPOVAN CF Trademark Renewal
The United States Patent and Trademark Office (USPTO) has renewed the trademark VETONE PROPOVAN CF, originally filed on August 11, 2016. The renewal is effective March 22, 2026, and pertains to veterinary preparations for animal healthcare, specifically a propofol injection anesthetic.
Nuclear Armageddon Trademark Renewal
The United States Patent and Trademark Office (USPTO) has renewed the trademark 'NUCLEAR ARMAGEDDON' (TM87133199) for dietary and nutritional supplements. The renewal is effective March 22, 2026.
USPTO Trademark Renewal for Dietary Supplements
The USPTO has renewed trademark application TM87126486 for dietary and nutritional supplements. The renewal is effective March 22, 2026, and continues the protection for a range of supplement products.
BEAT IT! Trademark Renewal for Insect Repellents
The USPTO has renewed the trademark 'BEAT IT!' (TM87138736) for insect repellents, with the renewal effective March 22, 2026. The original filing date for this trademark was August 15, 2016.
AJOSTAR Trademark Renewal
The USPTO has renewed the AJOSTAR trademark (TM87131588), which covers a range of pharmaceutical and medicinal products. The renewal is effective March 22, 2026, and maintains the trademark's protection for its listed goods.
USPTO Patent Application: Bioinformatics System Bandwidth Architecture
The USPTO has published a patent application (US20260081839A1) for a network bandwidth architecture designed for bioinformatics systems. The invention aims to control data transfers, including patient data and metadata, between various data repositories for analysis by life science service providers.
USPTO Patent Application for Data Streaming and Aggregation
The USPTO has published a new patent application (US20260081889A1) by Oracle International Corporation for techniques related to data streaming and aggregation with client-initiated recovery. The application details methods for managing data messages, detecting error conditions, and re-providing data to a computing system.
USPTO Patent Application: Blockchain for Clinical and Genetic Data
The USPTO has published a patent application (US20260082175A1) detailing a blockchain solution for harmonizing and storing clinical and genetic data. The application, assigned to Columbia University, aims to facilitate precision medicine by creating cohorts and identifying relationships between data types.
USPTO Patent Application: Emergency Vehicle Transport and Healthcare Communications System
The USPTO has published a patent application detailing a system for optimizing emergency vehicle transport and healthcare communications. The application describes methods for obtaining patient and medical device data, predicting optimal healthcare facility destinations, and transmitting medical data to those facilities.
USPTO Patent Application: 3D Immunomechanical Organoid Model
The USPTO has published a patent application (US20260079151A1) for a 3D immunomechanical organoid model developed by the University of Notre Dame. This model is designed for observing myeloid cell interactions and for applications in drug screening and microgravity experiments.
USPTO Patent Application: Neuron Generation from Pluripotent Stem Cells
The USPTO has published a patent application (US20260079153A1) detailing methods for generating mature neurons from pluripotent stem cells. The disclosed methods involve overexpressing specific splicing factors to facilitate the study of neurodegenerative diseases and the accelerated derivation of mature neurons.
USPTO Patent Application for Magnetic Separation of Biological Populations
The USPTO has published a new patent application (US20260079086A1) detailing an apparatus, system, and method for high-yield magnetic separation of biological populations. The application describes a system involving a cell engineering cassette, a fluidic pathway with entrapment features, and a translatable magnet array for separating subpopulations.
USPTO Patent Application: VOCs for Cellular Communication
The USPTO has published patent application US20260079169A1, detailing a method for evaluating cancer behavior using volatile organic compounds (VOCs) detected in a mutual headspace between cancer cells and control samples. The application, filed on November 24, 2025, by inventors from institutions including Technion-Israel Institute of Technology, outlines a novel diagnostic approach.
USPTO Patent Application: Pathogen Surrogates for Fresh Produce Sanitation
The USPTO has published a patent application (US20260079142A1) detailing pathogen surrogates with DNA tags for verifying sanitation systems in fresh produce processing. The application describes a method using these surrogates to mimic pathogen behavior during sanitation and subsequent DNA detection.
USPTO Patent Application for Tau Phospho Binding Antibodies
The USPTO has published a patent application (US20260079168A1) for Tau phospho binding antibodies and antigen binding fragments thereof. The application, filed on September 15, 2025, relates to methods for detecting Tau phospho (Thr217) and potential diagnostic or therapeutic uses for diseases associated with it.
USPTO Patent Application for Multivalent CLTX-CAR γδ T-cells
The USPTO has published a patent application (US20260078529A1) for multivalent CLTX-CAR γδ T-cells, which are designed for treating cancer or tumors. The application details specific T-cell compositions, pharmaceutical formulations, and methods of co-administering these cells with chemotherapeutic agents.
USPTO Patent Application: Orthogonal Mutations for Heterodimerization
The USPTO has published a patent application (US20260078202A1) detailing orthogonal mutations for heterodimerizing domains, particularly in antibody CH3 domains. This application, filed on April 25, 2025, by Jonathan Harry Davis and Nicholas M. Marshall, describes heterodimeric polypeptides and antibody constructs.
USPTO Patent Application: Ultrasensitive Immunoassay Method and Reagents
The USPTO has published a patent application detailing a new method and reagents for ultrasensitive detection of target molecules using reconstituted functional proteins. The invention aims to improve specificity and signal-to-noise ratios in various assay formats, including those for detecting viruses, bacteria, and proteins.
USPTO Patent Application for Organic Light-Emitting Device Compound
The USPTO has published a patent application (US20260082806A1) for a new compound and an organic light-emitting device incorporating it. The application details a compound of Chemical Formula 1, which may offer low driving voltage, high light emitting efficiency, or a long service life.
USPTO Patent Application: Organic Electroluminescent Materials and Devices
The USPTO has published a patent application by Universal Display Corporation for organic electroluminescent materials and devices. The application details organometallic compounds, formulations, and organic light emitting devices (OLEDs) utilizing these compounds.
USPTO Patent Application: Light Emitting Element and Polycyclic Compound
The USPTO has published a patent application for a novel polycyclic compound and a light emitting element that includes it. The application, filed on November 19, 2025, aims to improve luminous efficiency in light emitting devices.
USPTO Patent Application: Heterocyclic Compound for Organic Light Emitting Devices
The USPTO has published a patent application detailing a novel heterocyclic compound for use in organic light-emitting devices (OLEDs). The application, filed by inventors from South Korea, claims improvements in driving voltage, light emission efficiency, and device lifetime.
USPTO Patent Application for Organic Optoelectronic Device Compound
The USPTO has published a patent application (US20260082808A1) detailing a new compound and composition for organic optoelectronic devices and display devices. The application was filed on September 8, 2025, and published on March 19, 2026.
USPTO Patent Application: Monitoring Structure Without Chip
The USPTO has published a patent application (US20260079119A1) for a "Monitoring structure without chip." The application, filed by Inventec (Pudong) Technology Corporation, describes a structure with monitoring components designed for sensing signals without relying on a traditional chip.
USPTO Patent Application: Image Processing for Monitoring Inserted Objects
The USPTO has published a patent application detailing a system for monitoring objects inserted into a patient's body using image processing and machine learning. The application, filed by Gabriel Fine and Nathan Silberman, describes a method for training models on annotated images to determine the spatial information of inserted objects within a patient.
USPTO Patent Application for Stabilising Nonwoven Fibres
The USPTO has published a patent application (US20260078537A1) for a method of stabilising nonwoven fibres using an adhesive or heat bonding process. The application, filed on April 5, 2024, by inventor Frantisek Riha-Scott, details a technique for improving the durability of nonwoven materials used in various articles.
USPTO Patent Application for Absorbent Article Management System
The USPTO has published patent application US20260079033A1 for an absorbent article management system. The application, filed on July 3, 2025, by Henrik Pettersson-Falk, describes data logger units and sensor units designed to monitor the hygienic state of absorbent articles.
USPTO Patent Application for Acoustic Wave Attenuation
The USPTO has published patent application US20260080854A1 for systems and methods for attenuating acoustic waves. The application describes an acoustic filter designed to selectively attenuate sound waves based on amplitude thresholds. This is a routine publication of a patent application.
USPTO Patent Application: Medication Container Inspection Device
The USPTO has published a new patent application for a medication container inspection device designed to detect defects. The application details an apparatus that includes an inspection system and a manipulator to enhance defect visibility during automated transport and inspection of medication containers.
Medical Device Visual Elements Controlled by Device State Patent Application
The USPTO has published a patent application (US20260080998A1) detailing a medical system where visual elements on a display are controlled by the device's state. This application, filed by inventors Daniel Vik and Sreelal Chandrasenan, describes a system with visual profiles to manage the appearance of elements associated with the medical device's functions.
USPTO Patent Application for Digital Therapeutics Combination Therapy
The USPTO has published patent application US20260080800A1 for a combination therapy involving digital therapeutics and non-digital interventions, such as medicinal agents, aimed at decreasing pro-inflammatory molecules. The application was filed by REMEPY HEALTH LTD.
Medical Device Data Back-Association System Patent Application
The USPTO has published a patent application (US20260080990A1) for a medical device data back-association system. The invention aims to streamline the process of associating infusion pump data with patient electronic medical records (EMRs) to improve data management and patient care.
USPTO Patent Application for Light Mapping Method
The USPTO has published a new patent application for a light mapping method developed by Eshwar Chandra Bharadwaj Sonti. The application details a process for plotting accumulated interior and exterior light data to create a light map with spectral and intensity data.
USPTO Patent Application for CT Machine Monitoring Video Generation
The USPTO has published a patent application from Siemens Shanghai Medical Equipment Ltd. for a method of generating monitoring videos for CT machines. The application details a process for identifying keyframes and bounding boxes around a monitored target to create real-time monitoring videos.
USPTO Patent Application for Charging-Induced Implant Operation
The USPTO has published a patent application for a charging-induced implant operation. The invention relates to switching an implantable hearing prosthesis to a night-time mode of operation upon detection of night-time recharging.
USPTO Patent Application for Medical Imaging Protocols
The USPTO has published a patent application (US20260080982A1) for systems and methods to generate medical imaging protocols. The application details a process for creating baseline study protocols based on patient information and imaging study aspects, incorporating contrast and radiation dose management techniques. The application was filed on September 7, 2023, and is scheduled for publication on March 19, 2026.
USPTO Patent Application for Medical Device Magnetic Sensors
The USPTO has published a new patent application (US20260081346A1) for a medical device featuring field concentrating antennas for magnetic position sensors. The application, filed on November 25, 2025, describes a device designed for endovascular or intraluminal procedures to enhance sensing or therapeutic field delivery.
Carboxyalkyl Chitosan Patent Application
The USPTO has published a patent application (US20260078203A1) for a carboxyalkyl chitosan. The application details compositions, manufacturing processes, and therapeutic applications in areas such as rheumatology, ophthalmology, and dermatology. The filing date was November 26, 2025.
USPTO Patent Application: Systems for Targeting Cancer Cells
The USPTO has published a new patent application, US20260078200A1, detailing systems and methods for targeting cancer cells using genetically modified immune cells. The application describes novel polypeptides and their use in killing target cancer cells.
Anti-PTK7 Antibody Patent Application
The USPTO has published a patent application (US20260078201A1) for an anti-PTK7 antibody. The antibody is described as inhibiting angiogenesis, tumor growth, and cancer, with potential therapeutic applications for angiogenesis-related diseases and PTK7-positive cancers.
USPTO Patent Application for Anti-CD38 Antibodies
The USPTO has published a patent application (US20260078199A1) for anti-CD38 antibodies, therapeutics, and diagnostics. The application, filed on July 14, 2025, details methods for treating autoimmune diseases and diagnostic assays.
USPTO Patent Application: Predicting Disease State by Analyzing cfDNA Fragments
The USPTO has published a patent application (US20260080975A1) filed by Foundation Medicine, Inc. The application describes methods for predicting disease states by analyzing cell-free DNA (cfDNA) fragments. This is a routine publication of a patent application.
USPTO Patent Application: HRD Cancer Classification and Treatment
The USPTO has published a patent application from Foundation Medicine, Inc. detailing systems and methods for classifying and treating homologous repair deficiency (HRD) cancers. The application describes models for identifying HRD-positive tumors and suggests combination therapies, such as FOLFIRINOX, for treatment.
USPTO Patent Application: T cell isolation methods
The USPTO has published patent application US20260079159A1 detailing methods for isolating and expanding specific types of T cells (CD127lo/− regulatory T cells) for potential use in treating immune system disorders. The application was filed on September 12, 2025.
USPTO Patent Application: Pyramidal Meditation Structure Device
The USPTO has published a patent application for a pyramidal meditation structure device. The application, filed by Rein Daloul, describes a structure with vertical beams, walls, an entrance, and integrated pipes with crystals intended to impart healing energy during meditation.
USPTO Patent Application: Sjögren's Syndrome Detection and Treatment
The USPTO has published a patent application detailing methods for detecting and treating Sjögren's syndrome using salivary exosomes. The application, filed by inventors from various institutions, outlines novel diagnostic and therapeutic approaches for the autoimmune disease.